Asia Training Consortium has endorsed the Masters in International Clinical Research and Technology for clinical research professionals.

The Asia Training Consortium (ATC) was founded in 2012 as a unified platform for pharmaceutical companies to establish common goals and share resources to provide world-class training and development in clinical research in Asia. It is currently a consortium of 17 companies, including large top 20 pharmaceutical companies such as Merck, Novartis, Pfizer, Astellas and AstraZeneca, Global CROs and training institutions including Edinburgh Napier University. This is the first endorsement from ATC of an academic qualification to meet the needs for further qualifications for research professionals.

The Masters in International Clinical Research and Technology was launched last year between Edinburgh Napier University and ClinTec International to support the development of clinical research staff throughout the world and has now been endorsed by the ATC. This innovative Masters programme is an exciting collaboration, which builds upon the clinical research and educational expertise that exists within these two organisations. The Masters programme is accessible globally and has enrolled students from 14 countries, including students based in UAE, Lebanon, South Africa, India and the Philippines as well as from France, Austria, Sweden, UK, Czech Republic, Slovenia, Lithuania, Croatia and Romania. This successful innovative industry / academic collaboration leading to a Masters Degree led to ClinTec being awarded the Microsoft Innovation of the Year Award 2014 at the UK's largest Business Award Ceremony, with guest speaker global entrepreneur, Sir Richard Branson. Over the last 5 years, ClinTec and Edinburgh Napier University have delivered clinical research courses to over 1,000 clinical professionals globally, with over 200 based in Asia.

ClinTec International is a global...

To continue reading